Rozspas MF 80mg/250mg Tablet
Marketer
Macrozz Healthcare
Salt Composition
Drotaverine (80mg) + Mefenamic Acid (250mg)
Overview Rozspas MF 80mg/250mg Tablet
Abdominal pain is effectively treated with the combined medication, StomaEase 80mg/250mg tablets. This formulation alleviates abdominal pain, bloating, discomfort, and cramping by inducing relaxation of the stomach and intestinal muscles. Simultaneously, it inhibits pain-inducing chemical signals. StomaEase 80mg/250mg tablets should be taken with meals, following your physician's prescribed dosage and regimen. Dosage is tailored to individual needs and response. Continue treatment as directed; premature discontinuation may lead to symptom recurrence and condition exacerbation. Inform your healthcare provider of all other medications you are currently using, as interactions are possible. Common side effects include diarrhea, nausea, vomiting, stomach upset, dry mouth, appetite loss, thirst, and heartburn. These are mostly transient and self-limiting. Report any concerning side effects promptly to your doctor. Dizziness and drowsiness may occur; avoid driving or tasks requiring concentration until the effects are known. Alcohol consumption should be avoided due to potential dizziness exacerbation. Prior to commencing treatment, discuss your pregnancy status (including plans for pregnancy), breastfeeding, and any liver or kidney conditions with your doctor to ensure appropriate dosage.
Primary Ingredients of Rozspas MF 80mg/250mg Tablet
No information provided. Please provide the text you wish to be rephrased.
Uses of Rozspas MF 80mg/250mg Tablet
Managing pain in the abdomen
Major Benefits of Rozspas MF 80mg/250mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 80mg/250mg Rozspas MF tablet whole; do not crush, chew, or divide it. Administer this medication with a meal.
Common Side effects of Rozspas MF 80mg/250mg Tablet:
- Nausea
- Vomiting
- Diarrhea
- Dryness in mouth
- Heartburn
- Vertigo
- Insomnia (difficulty in sleeping)
- Hypotension (low blood pressure)
- Fast heart rate
- Sweating
- Constipation
- Increased liver enzymes
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Purpura
- Agranulocytosis (deficiency of granulocytes in the blood)
- Breathlessness
- Ringing in ear
- Abdominal pain
- Flatulence
- Indigestion
- Stomach inflammation
- Confusion
- Depression
How to use Rozspas MF 80mg/250mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 80mg/250mg Rozspas MF Tablet whole; avoid chewing, crushing, or breaking it. Administer this medicine with a meal.
How Rozspas MF 80mg/250mg Tablet works:
Combiflam MF 80mg/250mg tablets combine drotaverine, a muscle relaxant easing abdominal spasms, with mefenamic acid, a non-steroidal anti-inflammatory drug (NSAID). This dual action targets both the cramping and inflammation responsible for abdominal discomfort. Drotaverine's antispasmodic properties specifically address smooth muscle contractions, while mefenamic acid reduces pain and swelling by inhibiting inflammatory chemical signals.
SAFETY ADVICE
AlcoholUNSAFE
Alcohol consumption alongside Rozspas MF 80mg/250mg tablets is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Rozspas MF 80mg/250mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice before use.
Breast feedingCONSULT YOUR DOCTOR
Data on the compatibility of Rozspas MF 80mg/250mg Tablet with breastfeeding is lacking. Seek medical advice from your physician.
DrivingUNSAFE
Driving ability may be impaired by Rozspas MF 80mg/250mg Tablets, a potential side effect of the medication, which includes vertigo.
KidneyCAUTION
Patients with impaired kidney function should exercise caution when using Rozspas MF 80mg/250mg tablets, potentially requiring a modified dosage. Medical advice is essential. Rozspas MF 80mg/250mg tablets are contraindicated in individuals with severely compromised kidney function.
LiverCAUTION
Patients with liver impairment should exercise caution when using Rozspas MF 80mg/250mg tablets. Dosage modification may be necessary. Physician consultation is recommended.
What if you forget to take Rozspas MF 80mg/250mg Tablet :
Should you forget to take your Rozspas MF 80mg/250mg Tablet, administer it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing pattern. Avoid taking a double dose.
Facts to Know About Rozspas MF 80mg/250mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Gastrointestinal system |
3,018 People bought this recently